X4 Pharmaceuticals Inc
NASDAQ:XFOR
Income Statement
Earnings Waterfall
X4 Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-107.5m
USD
|
Operating Income
|
-107.5m
USD
|
Other Expenses
|
6.4m
USD
|
Net Income
|
-101.2m
USD
|
Income Statement
X4 Pharmaceuticals Inc
Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
4
N/A
|
4
N/A
|
4
N/A
|
0
N/A
|
3
N/A
|
3
N/A
|
3
N/A
|
3
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(24)
|
(26)
|
(27)
|
(30)
|
(36)
|
(42)
|
(48)
|
(48)
|
(49)
|
(48)
|
(50)
|
(49)
|
(47)
|
(51)
|
(52)
|
(56)
|
(63)
|
(67)
|
(72)
|
(74)
|
(75)
|
(79)
|
(81)
|
(82)
|
(88)
|
(96)
|
(101)
|
(108)
|
(108)
|
|
Selling, General & Administrative |
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(9)
|
(11)
|
(12)
|
(18)
|
(19)
|
(20)
|
(21)
|
(17)
|
(18)
|
(18)
|
(20)
|
(21)
|
(22)
|
(23)
|
(23)
|
(25)
|
(27)
|
(27)
|
(28)
|
(27)
|
(27)
|
(30)
|
(32)
|
(36)
|
|
Research & Development |
(18)
|
(20)
|
(20)
|
(23)
|
(28)
|
(32)
|
(37)
|
(36)
|
(31)
|
(29)
|
(28)
|
(27)
|
(30)
|
(33)
|
(34)
|
(37)
|
(42)
|
(45)
|
(49)
|
(51)
|
(51)
|
(53)
|
(53)
|
(54)
|
(61)
|
(69)
|
(71)
|
(76)
|
(72)
|
|
Operating Income |
(24)
N/A
|
(26)
-8%
|
(27)
-1%
|
(30)
-14%
|
(36)
-20%
|
(42)
-15%
|
(48)
-16%
|
(48)
+0%
|
(46)
+4%
|
(44)
+3%
|
(46)
-4%
|
(45)
+2%
|
(47)
-3%
|
(48)
-2%
|
(49)
-3%
|
(53)
-8%
|
(60)
-13%
|
(67)
-12%
|
(72)
-6%
|
(74)
-3%
|
(75)
-2%
|
(79)
-5%
|
(81)
-2%
|
(82)
-1%
|
(88)
-8%
|
(96)
-9%
|
(101)
-5%
|
(108)
-7%
|
(108)
+0%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
6
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(6)
|
(5)
|
(5)
|
(5)
|
(0)
|
(0)
|
0
|
0
|
0
|
(10)
|
(9)
|
(9)
|
(9)
|
1
|
0
|
0
|
0
|
0
|
|
Total Other Income |
3
|
2
|
3
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(4)
|
1
|
(28)
|
(3)
|
1
|
|
Pre-Tax Income |
(23)
N/A
|
(25)
-8%
|
(25)
-2%
|
(28)
-10%
|
(34)
-21%
|
(39)
-15%
|
(46)
-16%
|
(45)
+2%
|
(43)
+4%
|
(43)
-1%
|
(45)
-3%
|
(51)
-15%
|
(53)
-3%
|
(53)
0%
|
(55)
-3%
|
(54)
+0%
|
(62)
-14%
|
(70)
-12%
|
(74)
-6%
|
(77)
-4%
|
(89)
-15%
|
(92)
-4%
|
(94)
-2%
|
(95)
-2%
|
(94)
+1%
|
(96)
-2%
|
(130)
-36%
|
(111)
+15%
|
(101)
+9%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(23)
|
(25)
|
(25)
|
(28)
|
(34)
|
(39)
|
(46)
|
(45)
|
(43)
|
(43)
|
(45)
|
(51)
|
(53)
|
(53)
|
(55)
|
(55)
|
(62)
|
(70)
|
(74)
|
(77)
|
(89)
|
(92)
|
(94)
|
(95)
|
(94)
|
(96)
|
(130)
|
(111)
|
(101)
|
|
Net Income (Common) |
(23)
N/A
|
(25)
-8%
|
(25)
-2%
|
(28)
-10%
|
(34)
-21%
|
(39)
-15%
|
(46)
-16%
|
(45)
+2%
|
(43)
+4%
|
(44)
-2%
|
(45)
-3%
|
(52)
-15%
|
(53)
-3%
|
(53)
+1%
|
(55)
-3%
|
(55)
+0%
|
(62)
-14%
|
(78)
-25%
|
(82)
-6%
|
(85)
-3%
|
(103)
-21%
|
(100)
+3%
|
(102)
-2%
|
(103)
-2%
|
(96)
+7%
|
(96)
+0%
|
(131)
-36%
|
(111)
+15%
|
(101)
+9%
|
|
EPS (Diluted) |
-12.77
N/A
|
-13.82
-8%
|
-14.13
-2%
|
-15.58
-10%
|
-14.24
+9%
|
-16.45
-16%
|
-19.15
-16%
|
-18.76
+2%
|
-18.07
+4%
|
-25.5
-41%
|
-3.42
+87%
|
-3.56
-4%
|
-4.63
-30%
|
-2.65
+43%
|
-2.73
-3%
|
-2.71
+1%
|
-3.09
-14%
|
-3.75
-21%
|
-3.1
+17%
|
-3.19
-3%
|
-3.99
-25%
|
-2.96
+26%
|
-2.86
+3%
|
-1.24
+57%
|
-1.52
-23%
|
-0.65
+57%
|
-0.77
-18%
|
-0.56
+27%
|
-0.57
-2%
|